Stay updated on Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial
Sign up to get notified when there's something new on the Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial page.

Latest updates to the Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe footer now displays site revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check24 days agoChange DetectedAn NIH site-wide notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology under an executive order.SummaryDifference0.8%

- Check31 days agoChange DetectedThe site’s displayed software revision changes from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check38 days agoChange DetectedThe footer site revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check59 days agoChange DetectedA new revision entry for v3.7.0 was added to the study record history, and the previous revision v3.6.6 was removed from the history.SummaryDifference0.1%

- Check80 days agoChange DetectedThe study’s record history now shows a new revision entry (v3.6.6) and removes the previous revision (v3.6.5), updating the version history.SummaryDifference0.1%

Stay in the know with updates to Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial page.